Measurement of Blood Pressure in Chronic Kidney Disease: Time to Change Our Clinical Practice - A Comprehensive Review.
Shankar Prasad NagarajuSrinivas Vinayak ShenoyIndu Ramachandra RaoMohan V BhojarajaDharshan RangaswamyRavindra Attur PrabhuPublished in: International journal of nephrology and renovascular disease (2022)
Chronic kidney disease (CKD) is extremely common all over the world and is strongly linked to cardiovascular disease (CVD). The great majority of CKD patients have hypertension, which raises the risk of cardiovascular disease (CVD), end-stage kidney disease, and mortality. Controlling hypertension in patients with CKD is critical in our clinical practice since it slows the course of the disease and lowers the risk of CVD. As a result, accurate blood pressure (BP) monitoring is crucial for CKD diagnosis and therapy. Three important guidelines on BP thresholds and targets for antihypertensive medication therapy have been published in the recent decade emphasizing the way we measure BP. For both office BP and out-of-office BP measuring techniques, their clinical importance in the management of hypertension has been well defined. Although BP measurement is widely disseminated and routinely performed in most clinical settings, it remains unstandardized, and practitioners frequently fail to follow the basic recommendations to avoid measurement errors. This may lead to misdiagnosis and wrong management of hypertension, especially in CKD patients. Here, we review presently available all BP measuring techniques and their use in clinical practice and the recommendations from various guidelines and research gaps emphasizing CKD patients.
Keyphrases
- chronic kidney disease
- end stage renal disease
- blood pressure
- clinical practice
- cardiovascular disease
- newly diagnosed
- peritoneal dialysis
- ejection fraction
- primary care
- healthcare
- emergency department
- metabolic syndrome
- high resolution
- skeletal muscle
- patient reported outcomes
- cardiovascular events
- weight loss
- bone marrow
- adipose tissue
- patient reported
- cardiovascular risk factors
- drug induced
- arterial hypertension
- smoking cessation